These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 870336)

  • 21. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
    Dyck LE
    Life Sci; 1989; 44(17):1149-56. PubMed ID: 2716465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
    Quock RM
    Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain.
    Durden DA; Philips SR
    J Neurochem; 1980 Jun; 34(6):1725-32. PubMed ID: 7381498
    [No Abstract]   [Full Text] [Related]  

  • 24. Dependence of brain tryptamine formation on tryptophan availability.
    Warsh JJ; Coscina DV; Godse DD; Chan PW
    J Neurochem; 1979 Apr; 32(4):1191-6. PubMed ID: 430080
    [No Abstract]   [Full Text] [Related]  

  • 25. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
    Luscombe G; Jenner P; Marsden CD
    Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptamine metabolism in depression.
    Coppen A; Shaw DM; Malleson A; Eccleston E; Gundy G
    Br J Psychiatry; 1965 Oct; 111(479):993-8. PubMed ID: 5833611
    [No Abstract]   [Full Text] [Related]  

  • 27. Levels of p-tyramine in rat brain after chronic administration of MAO-inhibiting antidepressants.
    Baker GB; Coutts RT; Legatt DF
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):779-82. PubMed ID: 6686709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification, distribution, metabolism, and function of meta and para tyramine, phenylethylamine and tryptamine in brain.
    Boulton AA
    Adv Biochem Psychopharmacol; 1976; 15():57-67. PubMed ID: 799463
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver.
    Wang Lu LJ; Domino E
    Biochem Pharmacol; 1976 Jul; 25(13):1521-7. PubMed ID: 1066131
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions.
    Sloan JW; Martin WR; Clements TH; Buchwald WF; Bridges SR
    J Neurochem; 1975 Mar; 24(3):523-32. PubMed ID: 1113126
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical pharmacology of benzo(b)thiophene analogs of harmaline and harmine.
    Bosin TR; Campaigne E; Maickel RP
    Life Sci I; 1972 Jul; 11(14):685-91. PubMed ID: 4656100
    [No Abstract]   [Full Text] [Related]  

  • 34. Subcellular distribution of 5-hydroxytryptamine in rat brain during development: effect of drugs and fasting.
    Tissari AH; Raunu EM
    J Neurochem; 1975 Jun; 24(6):1143-50. PubMed ID: 1079237
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
    Morinan A; Collier JG
    Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of drugs related to alpha-ethyltryptamine on stress-induced ACTH secretion in the dog.
    Lorenzen LC; Ganong WF
    Endocrinology; 1967 May; 80(5):889-92. PubMed ID: 4290302
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells.
    Lee HT; Choi MR; Doh MS; Jung KH; Chai YG
    Oncol Rep; 2013 Oct; 30(4):1587-92. PubMed ID: 23900512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-tryptophan on mouse brain 5-hydroxytryptamine: comparison of values obtained using a fluorimetric assay and a liquid Chromatographic assay with electrochemical detection.
    Marsden CA
    J Neurochem; 1981 May; 36(5):1621-6. PubMed ID: 7241125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.